Literature DB >> 19006237

Mutations in NR2E3 can cause dominant or recessive retinal degenerations in the same family.

Pascal Escher1, Peter Gouras, Raphaël Roduit, Leila Tiab, Sylvain Bolay, Tania Delarive, Shiming Chen, Chih-Cheng Tsai, Masanori Hayashi, Jana Zernant, Joanna E Merriam, Nicolas Mermod, Rando Allikmets, Francis L Munier, Daniel F Schorderet.   

Abstract

NR2E3, a photoreceptor-specific nuclear receptor (PNR), represses cone-specific genes and activates several rod-specific genes. In humans, mutations in NR2E3 have been associated with the recessively-inherited enhanced short-wavelength sensitive S-cone syndrome (ESCS) and, recently, with autosomal dominant (ad) retinitis pigmentosa (RP) (adRP). In the present work, we describe two additional families affected by adRP that carry a heterozygous c.166G>A (p.G56R) mutation in the NR2E3 gene. Functional analysis determined the dominant negative activity of the p.G56R mutant protein as the molecular mechanism of adRP. Interestingly, in one pedigree, the most common causal variant for ESCS (p.R311Q) cosegregated with the adRP-linked p.G56R mutation, and the compound heterozygotes exhibited an ESCS-like phenotype, which in 1 of the 2 cases was strikingly "milder" than the patients carrying the p.G56R mutation alone. Impaired repression of cone-specific genes by the corepressors atrophin-1 (dentatorubral-pallidoluysian atrophy [DRPLA] gene product) and atrophin-2 (arginine-glutamic acid dipeptide repeat [RERE] protein) appeared to be a molecular mechanism mediating the beneficial effect of the p.R311Q mutation. Finally, the functional dominance of the p.R311Q variant to the p.G56R mutation is discussed. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19006237      PMCID: PMC3658139          DOI: 10.1002/humu.20858

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  35 in total

1.  Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate.

Authors:  N B Haider; S G Jacobson; A V Cideciyan; R Swiderski; L M Streb; C Searby; G Beck; R Hockey; D B Hanna; S Gorman; D Duhl; R Carmi; J Bennett; R G Weleber; G A Fishman; A F Wright; E M Stone; V C Sheffield
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

2.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  SWISS-MODEL: An automated protein homology-modeling server.

Authors:  Torsten Schwede; Jürgen Kopp; Nicolas Guex; Manuel C Peitsch
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice.

Authors:  N B Haider; J K Naggert; P M Nishina
Journal:  Hum Mol Genet       Date:  2001-08-01       Impact factor: 6.150

5.  Protein binding of a DRPLA family through arginine-glutamic acid dipeptide repeats is enhanced by extended polyglutamine.

Authors:  H Yanagisawa; M Bundo; T Miyashita; Y Okamura-Oho; K Tadokoro; K Tokunaga; M Yamada
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

6.  The photoreceptor cell-specific nuclear receptor gene (PNR) accounts for retinitis pigmentosa in the Crypto-Jews from Portugal (Marranos), survivors from the Spanish Inquisition.

Authors:  S Gerber; J M Rozet; S I Takezawa; L C dos Santos; L Lopes; O Gribouval; C Penet; I Perrault; D Ducroq; E Souied; M Jeanpierre; S Romana; J Frézal; F Ferraz; R Yu-Umesono; A Munnich; J Kaplan
Journal:  Hum Genet       Date:  2000-09       Impact factor: 4.132

7.  The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration.

Authors:  Ann H Milam; Linda Rose; Artur V Cideciyan; Mark R Barakat; Wai-Xing Tang; Nisha Gupta; Tomas S Aleman; Alan F Wright; Edwin M Stone; Val C Sheffield; Samuel G Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

8.  Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors.

Authors:  Hong Cheng; Hemant Khanna; Edwin C T Oh; David Hicks; Kenneth P Mitton; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2004-06-09       Impact factor: 6.150

9.  Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration.

Authors:  Dror Sharon; Michael A Sandberg; Rafael C Caruso; Eliot L Berson; Thaddeus P Dryja
Journal:  Arch Ophthalmol       Date:  2003-09

10.  Phenotypic variation in enhanced S-cone syndrome.

Authors:  Isabelle Audo; Michel Michaelides; Anthony G Robson; Marko Hawlina; Veronika Vaclavik; Jennifer M Sandbach; Magella M Neveu; Chris R Hogg; David M Hunt; Anthony T Moore; Alan C Bird; Andrew R Webster; Graham E Holder
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

View more
  28 in total

1.  A novel mutation (Cys83Tyr) in the second zinc finger of NR2E3 in enhanced S-cone syndrome.

Authors:  Amândio Rocha-Sousa; Takaaki Hayashi; Nuno Lourenço Gomes; Susana Penas; Elisete Brandão; Paulo Rocha; Mitsuyoshi Urashima; Hisashi Yamada; Hiroshi Tsuneoka; Fernando Falcão-Reis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-20       Impact factor: 3.117

2.  Excess cones in the retinal degeneration rd7 mouse, caused by the loss of function of orphan nuclear receptor Nr2e3, originate from early-born photoreceptor precursors.

Authors:  Hong Cheng; Naheed W Khan; Jerome E Roger; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2011-08-03       Impact factor: 6.150

3.  In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3.

Authors:  Qiong Qin; Anna Knapinska; Nicoleta Dobri; Franck Madoux; Peter Chase; Peter Hodder; Konstantin Petrukhin
Journal:  J Ocul Pharmacol Ther       Date:  2012-10-25       Impact factor: 2.671

4.  Molecular Heterogeneity Within the Clinical Diagnosis of Pericentral Retinal Degeneration.

Authors:  Rodrigo Matsui; Artur V Cideciyan; Sharon B Schwartz; Alexander Sumaroka; Alejandro J Roman; Malgorzata Swider; Wei Chieh Huang; Rebecca Sheplock; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

5.  Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Andrea Sodi; Ilaria Passerini; Dario Giorgio; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-15       Impact factor: 3.117

6.  Differential dimerization of variants linked to enhanced S-cone sensitivity syndrome (ESCS) located in the NR2E3 ligand-binding domain.

Authors:  Désirée von Alpen; Hoai Viet Tran; Nicolas Guex; Giulia Venturini; Francis L Munier; Daniel F Schorderet; Neena B Haider; Pascal Escher
Journal:  Hum Mutat       Date:  2015-04-27       Impact factor: 4.878

Review 7.  Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario.

Authors:  Muhammad Umar Ali; Muhammad Saif Ur Rahman; Jiang Cao; Ping Xi Yuan
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

8.  Disruption of the human cone photoreceptor mosaic from a defect in NR2E3 transcription factor function in young adults.

Authors:  Sung Pyo Park; In Hwan Hong; Stephen H Tsang; Winston Lee; Jason Horowitz; Suzanne Yzer; Rando Allikmets; Stanley Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-19       Impact factor: 3.117

9.  A comprehensive analysis of sequence variants and putative disease-causing mutations in photoreceptor-specific nuclear receptor NR2E3.

Authors:  Atsuhiro Kanda; Anand Swaroop
Journal:  Mol Vis       Date:  2009-10-24       Impact factor: 2.367

10.  Mutations in the DNA-binding domain of NR2E3 affect in vivo dimerization and interaction with CRX.

Authors:  Raphael Roduit; Pascal Escher; Daniel F Schorderet
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.